Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumors

Cancer immunotherapy encounters challenges of a low treatment response rate due to the tumor immunosuppressive microenvironment and immune-related adverse events caused by off-target immunotherapy agents delivered through systemic administration in clinical practice. Photodynamic therapy (PDT) offer...

Full description

Saved in:
Bibliographic Details
Main Authors: Shaozhen Wang, Chen Yang, Yuanyuan Zhang, Yi Hu, Lan Xiao, Weiping Ding, Bensheng Qiu, Fenfen Li
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006425002273
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849343563239784448
author Shaozhen Wang
Chen Yang
Yuanyuan Zhang
Yi Hu
Lan Xiao
Weiping Ding
Bensheng Qiu
Fenfen Li
author_facet Shaozhen Wang
Chen Yang
Yuanyuan Zhang
Yi Hu
Lan Xiao
Weiping Ding
Bensheng Qiu
Fenfen Li
author_sort Shaozhen Wang
collection DOAJ
description Cancer immunotherapy encounters challenges of a low treatment response rate due to the tumor immunosuppressive microenvironment and immune-related adverse events caused by off-target immunotherapy agents delivered through systemic administration in clinical practice. Photodynamic therapy (PDT) offers a viable approach to improve the immunotherapy efficacy through inducing immunogenic tumor cell death and is particularly advantageous in superficial tumor treatment. Therefore, leveraging integrated nanomaterials for photo-immunotherapy appears to be an ideal strategy to improve therapeutic outcome. In this study, we develop a transdermal-enhancing peptide (TD)-modified cationic liposome that simultaneously encapsulated with photosensitizer chlorine 6 (Ce6) and immunoadjuvant CpG, denoted as Ce6/CpG@Lip-TD, to mediate photo-immunotherapy of superficial tumors via the skin. The functionalization of TD peptide and positively charged surface endow the liposomes enhanced skin penetration capability. The combination of Ce6 and CpG within the liposomes synergistically potentiates the photo-immunotherapy effect when exposed to laser irradiation. In both melanoma and breast cancer murine models, Ce6/CpG@Lip-TD demonstrated substantial tumor-suppressing properties, along with an augmented systemic immune response against distal tumors. As a topical therapeutic agent, Ce6/CpG@Lip-TD circumvents the regulatory challenges associated with the systemic delivery of nanomaterials and significantly reduces systemic side effects, holding great promise for rapid translation into clinical applications.
format Article
id doaj-art-0e0f6c0d5ea34072b8d93fe12779b8a7
institution Kabale University
issn 2590-0064
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj-art-0e0f6c0d5ea34072b8d93fe12779b8a72025-08-20T03:42:56ZengElsevierMaterials Today Bio2590-00642025-06-013210166910.1016/j.mtbio.2025.101669Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumorsShaozhen Wang0Chen Yang1Yuanyuan Zhang2Yi Hu3Lan Xiao4Weiping Ding5Bensheng Qiu6Fenfen Li7Medical Imaging Center, Department of Electronic Engineering and Information Science, University of Science and Technology of China, Hefei, Anhui, 230026, ChinaMedical Imaging Center, Department of Electronic Engineering and Information Science, University of Science and Technology of China, Hefei, Anhui, 230026, ChinaSchool of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, China; Suzhou Institute for Advanced Research, University of Science and Technology of China, Suzhou, 215123, ChinaDepartment of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230027, ChinaDepartment of Gynecology Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230031, ChinaMedical Imaging Center, Department of Electronic Engineering and Information Science, University of Science and Technology of China, Hefei, Anhui, 230026, China; Department of Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China; Corresponding author. Medical Imaging Center, Department of Electronic Engineering and Information Science, University of Science and Technology of China, Hefei, Anhui, 230026, ChinaMedical Imaging Center, Department of Electronic Engineering and Information Science, University of Science and Technology of China, Hefei, Anhui, 230026, China; Corresponding author.Medical Imaging Center, Department of Electronic Engineering and Information Science, University of Science and Technology of China, Hefei, Anhui, 230026, China; Corresponding author.Cancer immunotherapy encounters challenges of a low treatment response rate due to the tumor immunosuppressive microenvironment and immune-related adverse events caused by off-target immunotherapy agents delivered through systemic administration in clinical practice. Photodynamic therapy (PDT) offers a viable approach to improve the immunotherapy efficacy through inducing immunogenic tumor cell death and is particularly advantageous in superficial tumor treatment. Therefore, leveraging integrated nanomaterials for photo-immunotherapy appears to be an ideal strategy to improve therapeutic outcome. In this study, we develop a transdermal-enhancing peptide (TD)-modified cationic liposome that simultaneously encapsulated with photosensitizer chlorine 6 (Ce6) and immunoadjuvant CpG, denoted as Ce6/CpG@Lip-TD, to mediate photo-immunotherapy of superficial tumors via the skin. The functionalization of TD peptide and positively charged surface endow the liposomes enhanced skin penetration capability. The combination of Ce6 and CpG within the liposomes synergistically potentiates the photo-immunotherapy effect when exposed to laser irradiation. In both melanoma and breast cancer murine models, Ce6/CpG@Lip-TD demonstrated substantial tumor-suppressing properties, along with an augmented systemic immune response against distal tumors. As a topical therapeutic agent, Ce6/CpG@Lip-TD circumvents the regulatory challenges associated with the systemic delivery of nanomaterials and significantly reduces systemic side effects, holding great promise for rapid translation into clinical applications.http://www.sciencedirect.com/science/article/pii/S2590006425002273Transdermal-enhancing peptideTransdermal deliveryCationic liposomesSuperficial tumorsPhoto-immunotherapy
spellingShingle Shaozhen Wang
Chen Yang
Yuanyuan Zhang
Yi Hu
Lan Xiao
Weiping Ding
Bensheng Qiu
Fenfen Li
Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumors
Materials Today Bio
Transdermal-enhancing peptide
Transdermal delivery
Cationic liposomes
Superficial tumors
Photo-immunotherapy
title Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumors
title_full Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumors
title_fullStr Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumors
title_full_unstemmed Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumors
title_short Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumors
title_sort co encapsulated ce6 cpg and biopeptide modified liposomes for enhanced transdermal photo immunotherapy of superficial tumors
topic Transdermal-enhancing peptide
Transdermal delivery
Cationic liposomes
Superficial tumors
Photo-immunotherapy
url http://www.sciencedirect.com/science/article/pii/S2590006425002273
work_keys_str_mv AT shaozhenwang coencapsulatedce6cpgandbiopeptidemodifiedliposomesforenhancedtransdermalphotoimmunotherapyofsuperficialtumors
AT chenyang coencapsulatedce6cpgandbiopeptidemodifiedliposomesforenhancedtransdermalphotoimmunotherapyofsuperficialtumors
AT yuanyuanzhang coencapsulatedce6cpgandbiopeptidemodifiedliposomesforenhancedtransdermalphotoimmunotherapyofsuperficialtumors
AT yihu coencapsulatedce6cpgandbiopeptidemodifiedliposomesforenhancedtransdermalphotoimmunotherapyofsuperficialtumors
AT lanxiao coencapsulatedce6cpgandbiopeptidemodifiedliposomesforenhancedtransdermalphotoimmunotherapyofsuperficialtumors
AT weipingding coencapsulatedce6cpgandbiopeptidemodifiedliposomesforenhancedtransdermalphotoimmunotherapyofsuperficialtumors
AT benshengqiu coencapsulatedce6cpgandbiopeptidemodifiedliposomesforenhancedtransdermalphotoimmunotherapyofsuperficialtumors
AT fenfenli coencapsulatedce6cpgandbiopeptidemodifiedliposomesforenhancedtransdermalphotoimmunotherapyofsuperficialtumors